Astrazeneca PLC (AZN)
Today's Latest Price: $53.57 USD
Updated Nov 24 4:00pm
Add AZN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
Astrazeneca Plc (AZN) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering AZN.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 22 | $77.12 | $42.06 | $61.7 | $54.7 | 12.8% |
AZN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 18 | 0 | 5 | 2 | 2 | 27 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AZN as an investment opportunity.
- Astrazeneca Plc's number of analysts covering the stock is greater than 94.76% of all US stocks.
- AZN has a lower percent of analysts bearish on the stock than 10.88% of Pharmaceutical Products stocks.
- AZN has a higher average analyst price target than 84.62% of Pharmaceutical Products stocks.
- Astrazeneca Plc's upside potential (average analyst target price relative to current price) is greater than 16.78% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of AZN is lower than 20.96% of all US stocks.
- AZN has a greater percentage of analysts bullish on the stock than 28.24% of Pharmaceutical Products stocks.
- AZN has a lower change in bullishness amongst analysts than just about 100% of all US stocks.
In the Pharmaceutical Products industry, CRSP, MDGL and GSK are the three stocks most similar to Astrazeneca Plc regarding the price target and analyst recommendation information presented here.
What is the outlook for AZN? Use POWR Ratings for clearer insight into price direction.
